EUVIMEDEUVIMED entdecken
Crossref

A GSH‐Responsive Prodrug with Simultaneous Triple‐Activation Capacity for Photodynamic/Sonodynamic Combination Therapy with Inhibited Skin Phototoxicity

Caiting Deng, Jingjing Zhang, Fanchun Hu, Shupeng Han, Meichen Zheng, Feifei An iD, Fu Wang

Small · 2024-10 · 20 (40)

DOI: 10.1002/smll.202400667 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, online erschienen am 05.06.2024. Verfasst von Caiting Deng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Engineering, School of Basic Medical Science, Health Science Center, Xi'an Jiaotong University, No. 76 Yanta West Road, Xi'an, S…. Hauptthemen laut MEDLINE: Prodrugs, Glutathione, Photochemotherapy, Skin. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shaanxi Province, Foreign Expert Project of Ministry of Science and Technology of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Herein, a dual‐sensitizer prodrug, named pro‐THPC, has been designed to function as both a photosensitizer and a sonosensitizer prodrug for precise antitumor combination therapy with minimized skin phototoxicity. Pro‐THPC could be activated by glutathione (GSH) to release the dual‐sensitizer, THPC, which simultaneously switches on fluorescence emission and combined capabilities of photodynamic therapy (PDT) and sonodynamic therapy (SDT). Pro‐THPC is further formulated into nanoparticles (NPs) for water dispersity to enable in vivo applications. In vivo fluorescence imaging shows that the pro‐THPC NPs group exhibits a significantly higher tumor‐to‐normal tissue ratio ( T / N ) ( T / N = 5.2 ± 0.55) compared to the “always on” THPC NPs group ( T / N = 2.9 ± 0.47) and the pro‐THPC NPs group co‐administrated with GSH synthesis inhibitor (buthionine sulfoximine, BSO) ( T / N = 3.2 ± 0.63). In addition, the generation of the designed dual‐sensitizer's reactive oxygen species (ROS) is effectively confined within the tumor tissues due to the relatively strong correlation between ROS generation and fluorescence emission. In vivo studies further demonstrate the remarkable efficacy of the designed pro‐THPC NPs to eradicate tumors through the combination of PDT and SDT while significantly reducing skin phototoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsGlutathionePhotochemotherapySkinAnimalsHumansPhotosensitizing AgentsCombined Modality TherapyReactive Oxygen SpeciesNanoparticlesUltrasonic TherapyCell Line, TumorMice

Stichwörter der Autor:innen

glutathionephotodynamic therapyprodrugsonodynamic therapytumor microenvironment

Substanzen

ProdrugsGlutathionePhotosensitizing AgentsReactive Oxygen Species

Autor:innen und Institutionen

  • Institute of Medical Engineering, School of Basic Medical Science, Health Science Center, Xi'an Jiaotong University, No. 76 Yanta West Road, Xi'an, Shaanxi, 710061, China.
  • School of Public Health, Health Science Center, Xi'an Jiaotong University, No.76 Yanta West Road, Xi'an, Shaanxi, 710061, China.
  • Xianyang Key Laboratory of Molecular Imaging and Drug Synthesis, School of Pharmacy, Shaanxi University of International Trade & Commerce, Xianyang, Shaanxi, 712046, China.

ORCID-Profile: Feifei An

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shaanxi Province
  • Foreign Expert Project of Ministry of Science and Technology of China

Zitieren

APA

Deng, C., Zhang, J., Hu, F., Han, S., Zheng, M., An, F., & Wang, F. (2024). A GSH‐Responsive Prodrug with Simultaneous Triple‐Activation Capacity for Photodynamic/Sonodynamic Combination Therapy with Inhibited Skin Phototoxicity. Small, 20(40). https://doi.org/10.1002/smll.202400667

Vancouver

Deng C, Zhang J, Hu F, Han S, Zheng M, An F, et al. A GSH‐Responsive Prodrug with Simultaneous Triple‐Activation Capacity for Photodynamic/Sonodynamic Combination Therapy with Inhibited Skin Phototoxicity. Small. 2024;20(40). doi:10.1002/smll.202400667

BibTeX
@article{Deng2024,
  author = {Deng, Caiting and Zhang, Jingjing and Hu, Fanchun and Han, Shupeng and Zheng, Meichen and An, Feifei and Wang, Fu},
  title = {A GSH‐Responsive Prodrug with Simultaneous Triple‐Activation Capacity for Photodynamic/Sonodynamic Combination Therapy with Inhibited Skin Phototoxicity},
  journal = {Small},
  year = {2024},
  volume = {20},
  number = {40},
  doi = {10.1002/smll.202400667}
}
Kostenlos starten →